D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 1.04M 1.04M 1.39M 1.97M 4.01M
Total Other Revenue -- -- -- -- --
Total Revenue 1.04M 1.04M 1.39M 1.97M 4.01M
Cost of Revenue 240.16M 219.17M 201.10M 183.40M 168.53M
Gross Profit -239.12M -218.13M -199.72M -181.43M -164.51M
SG&A Expenses 99.74M 88.64M 78.23M 66.73M 58.09M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 339.89M 307.81M 279.33M 250.13M 226.62M
Operating Income -338.85M -306.77M -277.95M -248.16M -222.61M
Income Before Tax -298.41M -277.91M -258.54M -235.46M -214.53M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -298.41 -277.91 -258.54 -235.46 -214.53
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -298.41M -277.91M -258.54M -235.46M -214.53M
EBIT -338.85M -306.77M -277.95M -248.16M -222.61M
EBITDA -336.07M -304.51M -276.19M -246.87M -221.51M
EPS Basic -3.70 -3.72 -3.77 -3.77 -3.70
Normalized Basic EPS -2.31 -2.32 -2.36 -2.36 -2.31
EPS Diluted -3.71 -3.72 -3.77 -3.78 -3.70
Normalized Diluted EPS -2.31 -2.32 -2.36 -2.36 -2.31
Average Basic Shares Outstanding 322.88M 298.53M 275.25M 250.52M 232.14M
Average Diluted Shares Outstanding 322.88M 298.53M 275.25M 250.52M 232.14M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings